Signal transducer and activator of transcription 5 (STAT5) (STAT5)

Signal transducer and activator of transcription 5 (STAT5), comprising the highly homologous isoforms STAT5A and STAT5B, is a critical transcription factor within the JAK-STAT signaling cascade (UniProt P42229, P51692). It is activated via phosphorylation of specific tyrosine residues (Y694 in STAT5A, Y699 in STAT5B) by Janus kinases (JAKs) or other tyrosine kinases in response to various cytokines and growth factors, such as erythropoietin, prolactin, and interleukins (PubMed: 29153476). Upon phosphorylation, STAT5 molecules form dimers and translocate to the nucleus, where they bind to specific DNA elements to initiate the transcription of genes essential for cell survival, proliferation, and differentiation (PubMed: 30333116). Dysregulation of STAT5, often characterized by its constitutive phosphorylation, is frequently observed in hematological malignancies like chronic myeloid leukemia (CML) and acute myeloid leukemia (AML), as well as solid tumors like breast and prostate cancer (StatPearls: JAK-STAT Pathway). Consequently, STAT5 is a high-priority therapeutic target, with research focusing on small molecules that inhibit its SH2 domain to prevent dimerization or upstream kinase inhibitors that block its activation (PubMed: 33431110).

Other names

STAT5ASTAT5BMammary gland factorMGFSTAT-5 phosphorylation

Direct inhibition of the SH2 domain to prevent dimerization and DNA binding, or indirect inhibition of upstream Janus kinases (JAKs) to prevent tyrosine phosphorylation.